Wyniki wyszukiwania - Biblioteka Nauki

Ten serwis zostanie wyłączony 2025-02-11.

Nowa wersja platformy, zawierająca wyłącznie zasoby pełnotekstowe, jest już dostępna.
Przejdź na https://bibliotekanauki.pl

Ograniczanie wyników

Znaleziono wyników: 3

Liczba wyników na stronie

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych: pediatric hospital

Sortuj według:

Ogranicz wyniki do:

Occurrence of antibiotic resistant enterococci in clinical specimens from a pediatric hospital

100%

Rudy M. , Zientara M. , Bek T. , Martirosian G.

nr 1

Enterococcal infection has become a major clinical problem and E. faecalis and E. faecium are the most frequently isolated species. However, the isolation of other species (E. casseliflavus, E. gallinarwn, E. durans) from clinical materials was reported recently. The aim of this study was to evaluate drug resistance of 97 species of enterococci isolated from clinical specimens of Upper Silesian Health Center of Child and Mother in Katowice. Each strain was tested for susceptibility to vancomycin, teicoplanin, aminoglycosides (gentamycin and streptomycin) and synercid (quinupristine/ dalfopristine) by the E-test method. Fifty three percent of studied enterococci demonstrated high level aminoglycoside resistance (HLAR) (MIC > 1024 μg/ml). Sixty three strains of E. faecalis were sensitive to vancomycin (MIC 1-4 μg/ml), but 5 strains demonstrated low sensitivity (3 strains with MIC = 6 μg/ml and 2 strains with MIC = 24 μg/ml). All studied enterococci were sensitive to teicoplanin (MIC < 2 μg/ml). A high percentage of E. faecium (70%) resistant to synercid was demonstrated (MIC = 2-24 μg/ml). Infection control and monitoring of antibiotic sensitivity among isolated hospital strains may prevent the transmission of resistant strains in a pediatric hospital.

Architectural solutions of contemporary pediatric hospitals - a study of selected projects

80%

Przesmycka N. , Strojny R.

2021

tom R.25, nr 3

88--91

The article presents the results of research on contemporary trends in the design of paediatric hospitals. The aim of the research was to determine directions both in the sphere of architectural, functionality and spatial solutions, as well as the arrangement of the areas of nursing and public areas, recognized as distinguishing features in relation to specialized hospitals of other profiles.

Artykuł przedstawia wyniki badań dotyczących współczesnych tendencji w zakresie projektowania szpitali pediatrycznych. Celem badań było określenie kierunków zarówno w sferze rozwiązań architektonicznych, funkcjonalno-przestrzennych, jak i aranżacji stref obszarów pielęgnacyjnych oraz ogólnodostępnych uznanych za wyróżniki w stosunku do szpitali specjalistycznych o innych profilach.

Incidence of extended-spectrum beta-lactamases in clinical isolates of the family Enterobacteriaceae in a pediatric hospital

80%

Radosz-Komoniewska H. , Gniadkowski M. , Rogala-Zawada D. , Nowakowska M. , Rudy M. , Wiechula B. , Martirosian G.

Polish Journal of Microbiology

2004

tom 53

nr 1

The incidence of extended-spectrum β-lactamases (ESBLs) was analyzed in Enterobacteriaceae population circulating in the Upper Silesian Child and Mother Health Center in Katowice (USC&MHC). Altogether 1164 clinical specimens, collected from children hospitalized in 8 different hospital units of USC&MHC were investigated. Five hundred and eighty-five clinical isolates of the family Enterobacteriaceae were identified in specimens collected from 403 patients. Two hundred and twenty-nine Enterobacteriaceae strains (39%) isolated from 162 patients were found to be putative ESBL producers as revealed by double-disc synergy (DDS) test. ESBL activity was the most prevalent in the population of Klebsiella pneumoniae (77%), followed by Klebsiella oxytoca (50%), Serratia marcescens (43%), Escherichia coli (30%), Enterobacter spp. (18%) and Proteus mirabilis (12%). ESBL producers demonstrated also wide resistance to the non-β-lactam antimicrobial co-trimoxazole (93%) and the aminoglycosides netilmicin (88%), gentamicin (84%) and amikacin (79%).